February 2020
- 03/03/2022
- FoI.20.083 IV MgSO4.pdf
-
-
- 03/03/2022
- FoI.20.081 Female Genital Mutilation.pdf
-
-
- 03/03/2022
- FoI.20.080 Cataract Surgery.pdf
-
-
- 03/03/2022
- FoI.20.078 Cancer Patients Treatment.pdf
-
-
- 03/03/2022
- FoI.20.077 Mesothelioma.pdf
-
-
- 03/03/2022
- FoI.20.076 Entyvio (vedolizumab).pdf
-
-
- 03/03/2022
- FoI.20.075 Acute Psychiatric Patients.pdf
-
-
- 03/03/2022
- FoI.20.74 Hate Crime Incidents.pdf
-
-
- 03/03/2022
- FoI.20.073 Clinical Insourcing.pdf
-
-
- 03/03/2022
- FoI.20.072 Adalimumab.pdf
-
-
- 03/03/2022
- FoI.20.072 Psoriasis Pathway 2017.pdf
-
-
- 03/03/2022
- FoI.20.072 UHW Biologic Pathway for RA.pdf
-
-
- 03/03/2022
- FoI.20.071 guidance.pdf
-
-
- 03/03/2022
- FoI.20.070 Welsh Gender Service.pdf
-
-
- 03/03/2022
- FoI.20.068 Acute Psychiatric Patients.pdf
-
-
- 03/03/2022
- FoI.20.067 IT Organisation Structure.pdf
-
-